CausalSentinel

Protein Dossier — SUMF1 (Formylglycine-generating enzyme)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Potassium in urine 0.0224 0.0075 0.00282 Inverse variance weighted 2 trans NA
Potassium in urine 0.0224 0.0075 0.00282 Inverse variance weighted 2 trans NA
Creatinine (enzymatic) in urine 0.0206 0.00708 0.00354 Inverse variance weighted 2 trans NA
Creatinine (enzymatic) in urine 0.0206 0.00708 0.00354 Inverse variance weighted 2 trans NA
Cough on most days 0.0901 0.0347 0.00941 Inverse variance weighted 2 trans NA
Cough on most days 0.0901 0.0347 0.00941 Inverse variance weighted 2 trans NA
Depressive symptoms -0.0391 0.0156 0.0124 Wald ratio 1 trans NA
Non-cancer illness code self-reported: diverticular disease or diverticulitis 0.144 0.0608 0.018 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: diverticular disease or diverticulitis 0.144 0.0608 0.018 Inverse variance weighted 2 trans NA
HDL cholesterol -0.0489 0.0219 0.0256 Wald ratio 1 trans NA
Non-cancer illness code self-reported: depression 0.0626 0.0286 0.0288 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: depression 0.0626 0.0286 0.0288 Inverse variance weighted 2 trans NA
…and 148 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

210 association rows across 113 traits (133 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating LRRN1 levels 1e-3269 rs9839475 7 GCST90860552 no MR -> candidate analysis
FAP/LRRN1 protein level ratio 5e-2494 rs3912619 1 GCST90314783 no MR -> candidate analysis
SETMAR protein levels 2e-279 rs35083095 10 GCST90470605 no MR -> candidate analysis
LRRN1 protein levels 5e-164 rs115770890 47 GCST90469806 no MR -> candidate analysis
Restless legs syndrome 8e-69 rs7620647 5 GCST90432061 no MR -> candidate analysis
SUMF1 protein levels 2e-52 rs35083095 1 GCST90470783 no MR -> candidate analysis
IL5RA protein levels 2e-31 rs4685615 3 GCST90469600 no MR -> candidate analysis
Refractive error 9e-25 rs1121798 5 GCST90841196 no MR -> candidate analysis
Leucine-rich repeat neuronal protein 1 levels (LRRN1.11293.1 2e-22 rs6801789 1 GCST90241762 no MR -> candidate analysis
Core binding factor acute myeloid leukemia 4e-15 rs6768756; rs11717189 2 GCST008413 no MR -> candidate analysis
Smoking initiation 5e-15 rs1312821 2 GCST90243985 no MR -> candidate analysis
Femur bone mineral density x serum urate levels interaction 3e-13 rs6805181 3 GCST012490 no MR -> candidate analysis
…and 101 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1451 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Multiple sulfatase deficiency 0.932 established (curated) no MR -> candidate analysis
mucosulfatidosis 0.608 established (curated) no MR -> candidate analysis
spinocerebellar ataxia type 15/16 0.669 established (curated) no MR -> candidate analysis
hereditary disease 0.56 established (curated) no MR -> candidate analysis
placenta praevia 0.531 common-variant locus no MR -> candidate analysis
alcohol drinking 0.528 common-variant locus no MR -> candidate analysis
hypertrophic cardiomyopathy 0.474 common-variant locus no MR -> candidate analysis
lower respiratory tract disorder 0.466 common-variant locus no MR -> candidate analysis
tooth disorder 0.397 common-variant locus no MR -> candidate analysis
uterine corpus leiomyoma 0.199 common-variant locus no MR -> candidate analysis
breast carcinoma 0.173 common-variant locus no MR -> candidate analysis
Uterine leiomyoma 0.162 common-variant locus no MR -> candidate analysis
atrial fibrillation 0.146 common-variant locus MR: beta=-0.0872, p=0.314 (trans)
atrial flutter 0.146 common-variant locus MR: beta=-0.0872, p=0.314 (trans)
benign neoplasm of adrenal gland 0.135 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=5.7e-17, LOEUF=1.28 — LoF-tolerant
GWAS Catalog 184 unique SNPs / 298 rows
ClinVar 1062 records; 15 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance